Sunday, November 24, 2024
11/24/2024
Louisiana’s Integrated Viral Hepatitis Surveillance and Prevention Project The surveillance and outbreak monitoring of Hepatitis A, B, and C are critical to understanding the epidemiology of viral hepatitis in Louisiana and the populations at risk. The activities of Component 1 will ensure timely detection of outbreaks and establish the capture of high quality data that will can be used for monitoring disease burden and direct prevention, treatment, and immunization activities. The activities of Component 2 will further the Louisiana Hepatitis C Elimination Plan’s tangible and incremental steps to increase access to prevention, harm reduction, diagnosis, and treatment using therapeutic interventions. Louisiana’s innovative subscription payment model is essential but insufficient on its own to realizing elimination. Advancing a multi-sectoral public health approach with effective and efficient technical, logistical, and administrative support structures will be critical to maximizing equitable access to therapeutic interventions before time runs out with the state’s pharmaceutical partnership at the end of 2024. The activities of Component 3 will address gaps in healthcare for people who inject drugs in Louisiana by utilizing innovative service delivery, evidence based practices and Syringe Service Program capacity building. In centralizing select services, the Louisiana STD/HIV/Hepatitis Program (SHHP) will allocate resources in Northern and Central LA, to strengthen services for both urban and rural people who inject drugs.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).
